|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 29, 2018 ) Hormone Replacement Therapy Market Overview:
In the year 2018, Europe Hormone Replacement Therapy Market was valued at USD 4.10 Billion. By the year 2023, it is expected to reach USD 5.68 Billion at pace of 6.75% CAGR.
Hormone replacement therapy is also known as postmenopausal hormone therapy or menopausal hormone therapy (MHT), refers to the treatment for the patients suffering from low levels of hormones in the body. Estrogen therapy (ET) is used to treat menopause symptoms which help to reduce sweating, vaginal dryness, disturbed sleep, hot flashes, and other symptoms. This treatment helps to restore hormone levels in the female, so that the body functions normally.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/request-sample
Underlying Causes
The growth for Market is driven due to factors like increasing geriatric population, rising prevalence of hormonal imbalance disorders, growing demand for hormone replacement therapy, increasing awareness about post-menopausal problems amongst women, and rising healthcare expenditure. In addition, technological advancements in the field of drug delivery systems and introduction of novel formulations are expected to drive the market growth. However, high risk of side effects like bloating, bleeding, mood changes, and nausea, high cost of therapy, and stringent regulatory policies are the restraining factors which is expected to decline the growth rate for Europe Hormone Replacement Therapy Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/
Geographic Segmentation:
Based on geography the Europe Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. France holds the largest market share in the Europe hormone replacement therapy market during the forecast period.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/customize-report
Key Players:
Leading companies for Europe market are Pfizer, Mylan Laboratories, Novartis, Merck & Co., Bayer, Amgen, Eli Lily, Novo Nordisk, F. Hoffmann-La Roche, Abbott Laboratories, Wyeth and Hisamitsu Pharmaceutical Co. Inc.
About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Filmnagar Branch, B 44, Rd Number 3, Journalist Colony, Hyderabad, Telangana 500033.
Phone: +1-888-702-9626
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
